Implantable Cardiac Device SCD Susceptibility Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implantable cardiac devices lack the capability to effectively indicate susceptibility to sudden cardiac death (SCD) and provide appropriate therapeutic responses, which is crucial for timely intervention in life-threatening conditions like ventricular fibrillation.

Innovation Solution

An implantable cardiac stimulation device that measures intrinsic rest rate, heart rate response, and heart rate recovery, comparing these metrics to predefined standards to determine SCD susceptibility and trigger a predetermined response, including notification and parameter adjustments, to address the susceptibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If implantable cardiac devices monitor heart rate metrics, then SCD susceptibility can be detected early, but device complexity increases due to multiple measuring circuits and comparators

Engineering Contradiction:
ImproveSCD susceptibility detectionVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device divides the SCD susceptibility assessment into three independent measuring circuits, each monitoring a specific heart rate metric (intrinsic rest rate, heart rate response, heart rate recovery). Each circuit operates independently and feeds data to a central comparator, allowing modular design and simplified maintenance while achieving comprehensive monitoring.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The implantable cardiac device integrates multiple functions including pacing, defibrillation, and SCD susceptibility monitoring into a single system. The same device that provides life-saving cardiac therapy also simultaneously monitors heart rate metrics to detect SCD risk, eliminating the need for separate monitoring devices.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Loss of time

If the device provides early indication of SCD susceptibility, then timely intervention is enabled, but false positives may cause unnecessary patient anxiety and interventions

Engineering Contradiction:
Improveresponse timeVSAvoiddetection accuracy
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The device continuously monitors heart rate metrics and provides real-time feedback to the comparator, which compares measured values against predetermined standards. This feedback mechanism enables dynamic assessment of SCD susceptibility and allows for timely intervention when thresholds are exceeded, while the standardized comparison criteria help filter false positives.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The device performs preliminary monitoring and assessment of heart rate metrics to identify SCD susceptibility before life-threatening events occur. By conducting these assessments in advance and comparing results against established standards, the system enables proactive intervention while reducing the risk of false alarms through objective criterion-based evaluation.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If multiple heart rate metrics are monitored simultaneously, then comprehensive SCD susceptibility assessment is achieved, but energy consumption increases

Engineering Contradiction:
Improveheart performance metrics analysisVSAvoidenergy consumption
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The device segments the monitoring function into three dedicated measuring circuits, each responsible for a specific heart rate metric. This segmentation allows each circuit to be optimized for its specific task, reducing overall energy consumption compared to a single comprehensive monitoring system, while still achieving precise multi-metric assessment.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS7753855B1Implantable cardiac device providing sudden cardiac death susceptibility indicator and method
Publication Date: 2010.07.13 PACESETTER INC
  • US7753855B1 patent drawing
  • US7753855B1 patent drawing
  • US7753855B1 patent drawing

AI summary

An implantable cardiac stimulation device determines sudden cardiac death susceptibility of a heart. The device comprises a first measuring circuit that measures intrinsic rest rate of the heart, a second measuring circuit that measures heart rate response of the heart and a third measuring circuit that measures heart rate recovery of the heart. The device further comprises a comparator that compares the measured intrinsic rest rate, the measured heart rate response, and the measured heart rate recovery to respective first, second, and third standards and a response circuit that provides a predetermined response when the comparisons of the measured intrinsic rest rate, the measured heart rate response, and the measured heart rate recovery to the respective standards indicate a susceptibility of sudden cardiac death.